.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Baxter
Dow
Mallinckrodt
Covington
Merck
Colorcon
Citi
Medtronic
Johnson and Johnson

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020645

« Back to Dashboard
NDA 020645 describes AMMONUL, which is a drug marketed by Medicis and is included in one NDA. It is available from three suppliers. Additional details are available on the AMMONUL profile page.

The generic ingredient in AMMONUL is sodium benzoate; sodium phenylacetate. There are one thousand three hundred and seventy-nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.

Summary for NDA: 020645

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 020645

Mechanism of ActionAmmonium Ion Binding Activity

Suppliers and Packaging for NDA: 020645

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMMONUL
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION) 020645 NDA Valeant Pharmaceuticals North America LLC 0187-0010 0187-0010-50 1 VIAL, SINGLE-USE in 1 CARTON (0187-0010-50) > 50 mL in 1 VIAL, SINGLE-USE
AMMONUL
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION) 020645 NDA Ucyclyd Pharma Inc. 62592-720 62592-720-50 1 VIAL, SINGLE-USE in 1 CARTON (62592-720-50) > 50 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength10%;10% (5GM/50ML;5GM/50ML)
Approval Date:Feb 17, 2005TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Moodys
UBS
Novartis
Chinese Patent Office
Cipla
Colorcon
Fuji
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot